Abstract
Patients with coronavirus disease 2019 (COVID-19) are at heightened risk of venous thromboembolic events (VTE), though there is no data examining when these events occur following a COVID-19 diagnosis. We therefore sought to characterize the incidence, timecourse of events, and outcomes of VTE during the COVID-19 pandemic in a national healthcare system using data from Veterans Affairs Administration.
Copyright © 2021 Elsevier Inc. All rights reserved.
MeSH terms
-
Aged
-
Anticoagulants / administration & dosage*
-
COVID-19 Nucleic Acid Testing
-
COVID-19* / complications
-
COVID-19* / epidemiology
-
COVID-19* / therapy
-
Chemoprevention / methods
-
Chemoprevention / statistics & numerical data
-
Female
-
Hospitalization / statistics & numerical data
-
Humans
-
Incidence
-
Male
-
Outcome Assessment, Health Care
-
Risk Assessment / statistics & numerical data
-
Risk Factors
-
SARS-CoV-2 / isolation & purification
-
United States / epidemiology
-
Venous Thromboembolism* / epidemiology
-
Venous Thromboembolism* / etiology
-
Venous Thromboembolism* / therapy
-
Veterans Health / statistics & numerical data*